Lessons from the Pandemic: Building a Better Prefilled Syringe

Prefilled syringes are increasingly being recognised as the safest method of packaging injectable drugs, and they offer a number of advantages when administering vaccines specifically. The sheer volume of injectables production necessitated by the pandemic has turned the spotlight on manufacturing processes and their ability to deliver high-quality products at scale in a short timespan. Inevitably this has also made manufacturers focus on the optimum design of prefilled syringes to balance performance, cost and ease of use. This whitepaper explores the challenges of packaging vaccines and how the design of prefilled syringes can be optimised through the selection of appropriate materials and components.